The Surprising Surge in One-Time Titans and the Weight-Loss Drugmaker at All-Time Highs 3/29/23

1

Introduction

00:00 • 2min

2

Intel and GE: The Highest Rally in Four Years

02:15 • 2min

3

The Dow's Outperformance in the First Quarter

04:01 • 3min

4

The Fed's Expectations for Q1 S&P Earnings

06:32 • 2min

5

The Economic Cycle Research Institute's Latest Weekly Data Finds a Hard Landing Outlook

08:44 • 2min

6

Coca-Cola's Weekly Leading Index Is Coming Back Down

10:42 • 2min

7

The Imminence of a Recession

12:46 • 2min

8

The Bear Markets Have Many Cycles

14:19 • 2min

9

Morgan Stanley Klein Earnings Alert on RH

16:02 • 2min

10

RH Furniture Drops After Hours on Weak Guidance and a Top and Bottom Line Miss

17:37 • 2min

11

Home Depot's Stock Is Not That Interesting

19:44 • 2min

12

Morgan Stanley's Client Experience: Old-School Wisdom With a Passion for What's Possible

21:18 • 2min

13

GE's Spinoff: What's Left of GE?

23:08 • 2min

14

The Future of the Market

25:02 • 3min

15

The Novo Trial Results Mean for the Weight Loss Market

28:05 • 2min

16

The Competitive Landscape for Lilly

29:49 • 2min

17

The Future of Obesity

31:26 • 2min

18

The Surgeon Anti-Obesity Drugs: Good Things Are Coming for Other Big Therapeutics Developers

33:18 • 2min

19

Amgen Bullish Activity Continues Into Earnings

35:02 • 2min

20

Trade or Fade?

37:01 • 2min

21

Shopify Gains More Than 13% This Month

38:33 • 2min

22

The Rise of Sports Betting Revenue in the US

40:06 • 3min

23

The Future of Sports Gambling

42:37 • 2min

24

Intel's App Performance After a Long Period of Significant Underperformance

44:48 • 2min